{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:53:29Z","timestamp":1787961209571,"version":"build-2784847793"},"reference-count":71,"publisher":"Informa UK Limited","issue":"3-4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Psychiatry in Clinical Practice"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1080\/13651501.2024.2436177","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T08:05:34Z","timestamp":1734595534000},"page":"189-197","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Agomelatine bears promising potential in treating bipolar depression\u2013 a systematic review"],"prefix":"10.1080","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9755-6720","authenticated-orcid":false,"given":"Junyao","family":"Li","sequence":"first","affiliation":[{"name":"Department of Psychiatry, the First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huirong","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, the First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, the First Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2015.07.017"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000329"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(93)90315-k"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(13)77272-9"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/164_2018_155"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23168983"},{"key":"e_1_3_4_8_1","first-page":"137","article-title":"Lessons learnt from an 8-week randomized, double-blind, controlled, parallel groups study on the efficacy and safety of agomelatine (25-50\u2009mg\/day orally) compared to placebo in bipolar i patients with a current major depressive episode","volume":"52","author":"Boyce P.","year":"2018","unstructured":"Boyce, P., Yatham, L., Picarel-Blanchot, F., & Bodinat, D. (2018). Lessons learnt from an 8-week randomized, double-blind, controlled, parallel groups study on the efficacy and safety of agomelatine (25-50\u2009mg\/day orally) compared to placebo in bipolar i patients with a current major depressive episode. Australian and New Zealand Journal of Psychiatry, 52, 137.","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291717000186"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2004.06.004"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00507.x"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1586\/17446651.3.2.269"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro201611610143-46"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.07.014"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001038"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.666541"},{"key":"e_1_3_4_17_1","unstructured":"European Union Drug Regulating Authorities Clinical Trials (EudraCT). Functional MRI (fMRI) after challenge and treatment with antidepressants and their relation to the clinical course to the Hypothalamus-Hypophysis-Adrenocortical Axis and the colon microbiome. https:\/\/www.clinicaltrialsregister.eu\/ctrsearch\/trial\/2013-003370-27\/DE#summary. EudraCT Number:2013-003370-27."},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S41557"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60512-6"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2012.11.004"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/hup.2759"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/15622975.2017.1384850"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-020-0723-y"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2022.113835"},{"key":"e_1_3_4_26_1","first-page":"135","article-title":"Efficacy and safety of agomelatine 25-50\u2009mg\/day versus escitalopram 10-20\u2009mg\/day in severe generalised anxiety disorder","volume":"21","author":"Khoo J. P.","year":"2019","unstructured":"Khoo, J. P., Stein, D., Ameringen, M. V., Hoschl, C., Ahokas, A., Bauer, M., Bitter, I., Jarema, M., Mosolov, S. N., Vavrusova, L., Picarel\u2010Blanchot, F., Olivier, V., & De Bodinat, C. (2019). Efficacy and safety of agomelatine 25-50\u2009mg\/day versus escitalopram 10-20\u2009mg\/day in severe generalised anxiety disorder. Bipolar Disorders, 21, 135.","journal-title":"Bipolar Disorders"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0121245"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(99)00052-4"},{"issue":"3","key":"e_1_3_4_29_1","first-page":"14","article-title":"Fluoxetine: Clinical pharmacology and physiologic disposition","volume":"46","author":"Lemberger L.","year":"1985","unstructured":"Lemberger, L., Bergstrom, R. F., Wolen, R. L., Farid, N. A., Enas, G. G., & Aronoff, G. R. (1985). Fluoxetine: Clinical pharmacology and physiologic disposition. The Journal of Clinical Psychiatry, 46(3\u2009Pt 2), 14\u201319.","journal-title":"The Journal of Clinical Psychiatry"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1021\/ja01543a060"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-1781(97)00128-5"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203586"},{"key":"e_1_3_4_33_1","first-page":"W65","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration","volume":"151","author":"Liberati A.","year":"2009","unstructured":"Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., G\u00f8tzsche, P. C., Ioannidis, J. P., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Journal of Clinical Epidemiology, 151, W65\u2013W94.","journal-title":"Journal of Clinical Epidemiology"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200209000-00004"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2021.102866"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867420979353"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.13165"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30264-4"},{"key":"e_1_3_4_39_1","first-page":"129","article-title":"Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: A systematic review and meta-analysis of randomised placebo-controlled trials","volume":"9","author":"Mcgirr A.","year":"2016","unstructured":"Mcgirr, A., Yatham, L. N., Vhringer, P. A., Ghaemi, N., & Lam, R. W. (2016). Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: A systematic review and meta-analysis of randomised placebo-controlled trials. Focus (American Psychiatric Publishing), 9, 129\u2013137.","journal-title":"Focus (American Psychiatric Publishing)"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31544-0"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2019.1636017"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.051797"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9568.2000.00982.x"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108096507"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00857-4"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1574747"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12270"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2021.110266"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0645-3"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2018.00624"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012453"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2011.05.005"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3181a5233f"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300203"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.15557\/PiPK.2019.0019"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2012.711314"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01583-9"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.353479"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-019-05385-y"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867414529339"},{"key":"e_1_3_4_61_1","first-page":"53","article-title":"A comparative evaluation of the efficacy of valdoxan (agomelatine) in recurrent depression and bipolar affective disorder","volume":"112","author":"Tiuvina Nas V. N.","year":"2012","unstructured":"Tiuvina Nas, V. N. (2012). A comparative evaluation of the efficacy of valdoxan (agomelatine) in recurrent depression and bipolar affective disorder. Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova, 112, 53\u201360.","journal-title":"Zhurnal Nevrologii i Psikhiatrii Imeni SS Korsakova"},{"key":"e_1_3_4_62_1","first-page":"10","article-title":"Agomelatine attenuates calcium signaling and apoptosis via the inhibition of TRPV1 channel in the hippocampal neurons of rats with chronic mild stress depression model","volume":"14","author":"\u00dcnal G. \u00d6.","year":"2022","unstructured":"\u00dcnal, G. \u00d6., Demirda\u0161, A., Naziro\u01e7lu, M., & \u00d6vey, I. S. (2022). Agomelatine attenuates calcium signaling and apoptosis via the inhibition of TRPV1 channel in the hippocampal neurons of rats with chronic mild stress depression model. Journal of Cellular Neuroscience and Oxidative Stress, 14, 10\u201312.","journal-title":"Journal of Cellular Neuroscience and Oxidative Stress,"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.17116\/jnevro20151151223-30"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.14412\/2074-2711-2022-1-52-59"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.13040"},{"key":"e_1_3_4_66_1","first-page":"55","article-title":"Failed trials in bipolar depression: Lessons learned from armodafinil and agomelatine","volume":"19","author":"Vieta E.","year":"2017","unstructured":"Vieta, E. (2017). Failed trials in bipolar depression: Lessons learned from armodafinil and agomelatine. Bipolar Disorders, 19, 55.","journal-title":"Bipolar Disorders,"},{"key":"e_1_3_4_67_1","volume-title":"Comparison of the effect of Agomelatine and Sertraline on bipolar depression","author":"Vojgani H.","year":"2020","unstructured":"Vojgani, H. (2020). Comparison of the effect of Agomelatine and Sertraline on bipolar depression. International Clinical Trials Registry Platform."},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1192\/pb.bp.113.043505"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12609"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.114.147587"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.2174\/2211556004666151008215220"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1192\/bja.2020.25"}],"container-title":["International Journal of Psychiatry in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13651501.2024.2436177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T03:58:45Z","timestamp":1743047925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13651501.2024.2436177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":71,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1080\/13651501.2024.2436177"],"URL":"https:\/\/doi.org\/10.1080\/13651501.2024.2436177","relation":{},"ISSN":["1365-1501","1471-1788"],"issn-type":[{"value":"1365-1501","type":"print"},{"value":"1471-1788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijpc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijpc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-09-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}